Humana Inc.

HUM

US4448591028

Managed Healthcare

Market Closed - Nyse Other stock markets 01:30:02 12/07/2025 am IST			5-day change	1st Jan Change
230.67 ^USD	-0.65%		-3.76%	-9.08%

11/07	Deutsche Bank Lowers Price Target on Humana to $224 From $262, Keeps Hold Rating	MT
10/07	Marsh Mclennan Appoints Bruce Broussard to Its Board of Directors, Effective July 9, 2025	CI

Humana Says Continue To Anticipate FY 2025 Net Patient Growth Of 30,000 To 50,000 Reflecting About 10% Growth At Midpoint

Published on 30/04/2025 at 15:53

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about Humana Inc.

Deutsche Bank Lowers Price Target on Humana to $224 From $262, Keeps Hold Rating	11/07	MT
Marsh Mclennan Appoints Bruce Broussard to Its Board of Directors, Effective July 9, 2025	10/07	CI
Centene shares plunge after health insurer withdraws forecast over Obamacare concerns	03/07	RE
Sector Update: Health Care Stocks Decline Wednesday Afternoon	02/07	MT
Humana Healthy Horizons Launches Medicaid Plan in Virginia	02/07	CI
Humana Launches Medicaid Plan in Virginia	02/07	MT
US Health Insurance Stocks Fall After Centene Withdraws 2025 EPS Guidance	02/07	MT
Raymond James Raises Price Target on Humana to $340 From $315, Maintains Outperform Rating	30/06	MT
Supreme Court Preserves 'Obamacare's Preventative Care Coverage Guarantee	27/06	MT
Humana Inc. Expands Science-Based Targets with New SBTi-Validated Target	24/06	CI
Humana Sets New Scope 3 Asset Class Level Target Aiming to Reduce Emissions From Lending Activities	24/06	MT
US health chief Kennedy gets pledge from insurers on prior authorization reform	24/06	RE
Health Insurers Pledge to Streamline Prior Authorization Process by 2027	23/06	MT
US Health Insurers Aim to Streamline Preapproval Process	20/06	MT
Humana Shows Multiple Levers to Drive EPS Growth, RBC Says	17/06	MT
Truist Cuts Price Target on Humana to $280 From $305, Keeps Hold Rating	17/06	MT
Truist Cuts Price Target on Humana to $280 From $305, Keeps Hold Rating	17/06	MT
Humana Inc. - Analyst/Investor Day	17/06
Mercy and Humana Team Up for the First Time to Open 65 Prime+ Clinics in Missouri	12/06	CI
Barclays Adjusts Price Target on Humana to $268 From $273	12/06	MT
Jefferies Adjusts Price Target on Humana to $244 From $287	11/06	MT
Wolfe Research Adjusts Price Target on Humana to $283 From $339, Maintains Outperform Rating	06/06	MT
PRESS DIGEST- Wall Street Journal - June 06	06/06	RE
Sector Update: Health Care Stocks Mixed Late Afternoon	06/06	MT
US Senate Republicans Consider Cutting Medicare Spending to Fund President's Tax Bill	06/06	MT

Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows: - health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals; - services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.; - other (1%).

Employees

65,680

Sector

Managed Healthcare

Calendar

30/07 - Q2 2025 Earnings Release

More about the company